Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 28, 1998 - Issue 12
Submit an article Journal homepage
1,101
Views
262
CrossRef citations to date
0
Altmetric
Research Article

Inhibition and induction of human cytochrome P450 (CYP) enzymes

O. PELKONEN Department of Pharmacology and Toxicology, University of Oulu, FIN-90220 Oulu, Finland OE Clinical Research, Leiras OY, PO Box 325, FIN-00101, Helsinki, Finland
,
J. MÄEENPÄEÄ Department of Pharmacology and Toxicology, University of Oulu, FIN-90220 Oulu, Finland OE Clinical Research, Leiras OY, PO Box 325, FIN-00101, Helsinki, Finland
,
P. TAAVITSAINEN Department of Pharmacology and Toxicology, University of Oulu, FIN-90220 Oulu, Finland OE Clinical Research, Leiras OY, PO Box 325, FIN-00101, Helsinki, Finland
,
A. RAUTIO Department of Pharmacology and Toxicology, University of Oulu, FIN-90220 Oulu, Finland OE Clinical Research, Leiras OY, PO Box 325, FIN-00101, Helsinki, Finland
&
H. RAUNIO Department of Pharmacology and Toxicology, University of Oulu, FIN-90220 Oulu, Finland OE Clinical Research, Leiras OY, PO Box 325, FIN-00101, Helsinki, Finland
Pages 1203-1253 | Published online: 22 Sep 2008

Citations (262)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (36)

Tomohiko Ichikawa, Hirofumi Tsujino, Takahiro Miki, Masaya Kobayashi, Chiaki Matsubara, Sara Miyata, Taku Yamashita, Kohei Takeshita, Yasushige Yonezawa & Tadayuki Uno. (2018) Allosteric activation of cytochrome P450 3A4 by efavirenz facilitates midazolam binding. Xenobiotica 48:12, pages 1227-1236.
Read now
Yuki Yamasaki, Kaoru Kobayashi, Asumi Inaba, Daisuke Uehara, Hiroki Tojima, Satoru Kakizaki & Kan Chiba. (2018) Indirect activation of pregnane X receptor in the induction of hepatic CYP3A11 by high-dose rifampicin in mice. Xenobiotica 48:11, pages 1098-1105.
Read now
Jukka Mäenpää & Olavi Pelkonen. (2016) Cardiac safety of ophthalmic timolol. Expert Opinion on Drug Safety 15:11, pages 1549-1561.
Read now
Aziz Eftekhari, Yadollah Azarmi, Alireza Parvizpur & Mohammad Ali Eghbal. (2016) Involvement of oxidative stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes. Xenobiotica 46:4, pages 369-378.
Read now
Wajd Amly & Rafik Karaman. (2016) Recent updates in utilizing prodrugs in drug delivery (2013–2015). Expert Opinion on Drug Delivery 13:4, pages 571-591.
Read now
Martina Galdíková, Katarína Šiviková, Beáta Holečková, Ján Dianovský, Monika Drážovská & Viera Schwarzbacherová. (2015) The effect of thiacloprid formulation on DNA/chromosome damage and changes in GST activity in bovine peripheral lymphocytes. Journal of Environmental Science and Health, Part B 50:10, pages 698-707.
Read now
Xiaoxiang Du, Huizhou Ye, Chunxia Zhang, Lei Ye & Guanyang Lin. (2015) Effect of kanglaite on rat cytochrome P450. Pharmaceutical Biology 53:7, pages 995-1001.
Read now
Jia Chen, Dongyang Liu, Xin Zheng, Qian Zhao, Ji Jiang & Pei Hu. (2015) Relative contributions of the major human CYP450 to the metabolism of icotinib and its implication in prediction of drug–drug interaction between icotinib and CYP3A4 inhibitors/inducers using physiologically based pharmacokinetic modeling. Expert Opinion on Drug Metabolism & Toxicology 11:6, pages 857-868.
Read now
Yohei Kosugi & Junzo Takahashi. (2015) Species differences and substrate specificity of CYP3A heteroactivation by efavirenz. Xenobiotica 45:4, pages 345-352.
Read now
Amrita Saxena, Girish K. Jain, Hefazat H. Siddiqui, Shom S. Bhunia, Anil K. Saxena & Jiaur R. Gayen. (2014) In vitro metabolism of a novel antithrombotic compound, S002-333, and its enantiomers: quantitative cytochrome P450 phenotyping, metabolic profiling and enzyme kinetic studies. Xenobiotica 44:4, pages 295-308.
Read now
Paul R Ortiz de Montellano. (2013) Cytochrome P450-Activated Prodrugs. Future Medicinal Chemistry 5:2, pages 213-228.
Read now
Kornphimol Kulthong, Rawiwan Maniratanachote, Yuki Kobayashi, Tatsuki Fukami & Tsuyoshi Yokoi. (2012) Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity. Xenobiotica 42:9, pages 854-862.
Read now
Yohei Kosugi, Hideki Hirabayashi, Tomoko Igari, Yasushi Fujioka, Yoko Hara, Teruaki Okuda & Toshiya Moriwaki. (2012) Evaluation of cytochrome P450-mediated drug–drug interactions based on the strategies recommended by regulatory authorities. Xenobiotica 42:2, pages 127-138.
Read now
Kyeong-Ryoon Lee, Yoon-Jee Chae, Jong-Hwa Lee, Dae-Duk Kim, Saeho Chong, Chang-Koo Shim & Suk-Jae Chung. (2012) QUANTIFICATION OF CILNIDIPINE IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY. Journal of Liquid Chromatography & Related Technologies 35:2, pages 308-320.
Read now
Nobuyuki Koga, Chiho Ohta, Yoshihisa Kato, Koichi Haraguchi, Tetsuya Endo, Kazunori Ogawa, Hideaki Ohta & Masamichi Yano. (2011) In vitro metabolism of nobiletin, a polymethoxy-flavonoid, by human liver microsomes and cytochrome P450. Xenobiotica 41:11, pages 927-933.
Read now
B. G. Lake. (2009) Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. Xenobiotica 39:8, pages 582-596.
Read now
Thomas G. Osimitz & Brian G. Lake. (2009) Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk. Critical Reviews in Toxicology 39:6, pages 501-511.
Read now
R. J. Price, M. P. Scott, A. M. Giddings, D. G. Walters, R. H. Stierum, C. Meredith & B. G. Lake. (2008) Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes. Xenobiotica 38:6, pages 574-586.
Read now
H. Raunio, N. Pokela, K. Puhakainen, M. Rahnasto, T. Mauriala, S. Auriola & R. O. Juvonen. (2008) Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo. Xenobiotica 38:1, pages 34-47.
Read now
O. Pelkonen & M. Turpeinen. (2007) extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 37:10-11, pages 1066-1089.
Read now
Jianling Wang, Laszlo Urban & Dejan Bojanic. (2007) Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 641-665.
Read now
Jos V Castell, Ramiro Jover, Celia P Martnez-Jimnez & Mara Jos Gmez-Lechn. (2006) Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opinion on Drug Metabolism & Toxicology 2:2, pages 183-212.
Read now
M. D. Lee, E. Ayanoglu & L. Gong. (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions. Xenobiotica 36:10-11, pages 1013-1080.
Read now
Alastair E. Cribb, Mathieu Peyrou, Shanmugam Muruganandan & Laetitia Schneider. (2005) The Endoplasmic Reticulum in Xenobiotic Toxicity. Drug Metabolism Reviews 37:3, pages 405-442.
Read now
D. Tenmizu, Y. Endo, K. Noguchi & H. Kamimura. (2004) Identification of the novel canine CYP1A2 1117 C>T SNP causing protein deletion. Xenobiotica 34:9, pages 835-846.
Read now
Shufeng Zhou, Yihuai Gao, Wenqi Jiang, Min Huang, Anlong Xu & James W. Paxton. (2003) Interactions of Herbs with Cytochrome P450. Drug Metabolism Reviews 35:1, pages 35-98.
Read now
David F. V. Lewis & Maruice Dickins. (2003) Baseline Lipophilicity Relationships in Human Cytochromes P450 Associated with Drug Metabolism. Drug Metabolism Reviews 35:1, pages 1-18.
Read now
Paavo Honkakoski, Tatsuya Sueyoshi & Masahiko Negishi. (2003) Drug-activated nuclear receptors CAR and PXR. Annals of Medicine 35:3, pages 172-182.
Read now
Jens Standop, Matthias B. Schneider, Alexis Ulrich, Subhash Chauhan, Nicolas Moniaux, Markus W. Büchler, Surinder K. Batra & Parviz M. Pour. (2002) The Pattern of Xenobiotic-Metabolizing Enzymes in the Human Pancreas. Journal of Toxicology and Environmental Health, Part A 65:19, pages 1379-1400.
Read now
Shufeng Zhou, Philip Kestell & James W. Paxton. (2002) PREDICTING PHARMACOKINETICS AND DRUG INTERACTIONS IN PATIENTS FROM IN VITRO AND IN VIVO MODELS: THE EXPERIENCE WITH 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA), AN ANTI-CANCER DRUG ELIMINATED MAINLY BY CONJUGATION. Drug Metabolism Reviews 34:4, pages 751-790.
Read now
Olavi Pelkonen. (2002) Human CYPs: in vivo and clinical aspects. Drug Metabolism Reviews 34:1-2, pages 37-46.
Read now
N. Hagen, A. K. Olsen, J. V. Andersen, J. Tjørnelund & S. H. Hansen. (2002) Characterization of mixtures of recombinant human cytochrome P450s as a screening model for metabolic stability in drug discovery. Xenobiotica 32:9, pages 749-759.
Read now
M. Rypka, J. Veselý, Z. Chmela, D. Riegrová, K. Červenková, L. Havlíček, K. Lemr, J. Hanuš, B. Černý, J. Lukeš & K. Michalíková. (2002) In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine by mouse liver microsomes. Xenobiotica 32:11, pages 1017-1031.
Read now
A. B. Renwick, G. Lavignette, P. D. Worboys, B. Williams, D. Surry, D. F. V. Lewis, R. J. Price, B. G. Lake & D. C. Evans. (2001) Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes. Xenobiotica 31:12, pages 861-878.
Read now
O. Pelkonen, P. Myllynen, P. Taavitsainen, A. R. Boobis, P. Watts, B. G. Lake, R. J. Price, A. B. Renwick, M.-J. Gómez-Lechón, J. V. Castell, M. Ingelman-Sundberg, M. Hidestrand, A. Guillouzo, L. Corcos, P. S. Goldfarb & D. F. V. Lewis. (2001) Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems. Xenobiotica 31:6, pages 321-343.
Read now
D. C. Mankowski, M. P. Lawton & S. Ekins. (2000) Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates. Xenobiotica 30:8, pages 745-754.
Read now

Articles from other publishers (226)

Jv-Liang Dai, Hao-Hong Chen & Jian-Guo Jiang. (2024) Imidazole as chemical stimulant induces the accumulation of β-cryptoxanthin in Dunaliella tertiolecta. Algal Research 77, pages 103336.
Crossref
Bo Wang, Sheng Zhang, Zi‐Tao Shen, Ting Hou, Yi‐Han Zhao, Meng‐Sheng Huang, Jian Li, Huan Chen, Peng‐Hui Hu, Zi‐Jiang Luo, Shuai Yuan, Feng‐Min Wang, Wei Li, Chang Shu, Xing‐Hua Xia & Ya Ding. (2023) Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation . Angewandte Chemie International Edition 62:50.
Crossref
Bo Wang, Sheng Zhang, Zi‐Tao Shen, Ting Hou, Yi‐Han Zhao, Meng‐Sheng Huang, Jian Li, Huan Chen, Peng‐Hui Hu, Zi‐Jiang Luo, Shuai Yuan, Feng‐Min Wang, Wei Li, Chang Shu, Xing‐Hua Xia & Ya Ding. (2023) Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation . Angewandte Chemie 135:50.
Crossref
Ahmad AinurofiqLutvi Ismaya. (2023) Pharmacokinetic Drug-Drug Interactions: A Systematic Review of the Cytochrome P450 (CYP) Isoenzyme 3A4. Research Journal of Pharmacy and Technology, pages 3016-3024.
Crossref
Maria Claudia Pinheiro Corôa, Paulo Fernando Santos Mendes, Daiane Claydes Baia-da-Silva, Deiweson Souza-Monteiro, Maria Karolina Martins Ferreira, Glenda Luciana Costa Braga, Taissa Viana Damasceno, José Messias Perdigão & Rafael Rodrigues Lima. (2022) What Is Known about Midazolam? A Bibliometric Approach of the Literature. Healthcare 11:1, pages 96.
Crossref
Gerhard Schwarz, Maximilian Errath, Placido Argüelles Delgado, Ulrike Wießpeiner, Henrika Voit-Augustin, Robert Grims, Friedrich Kaltenböck, Eva Maria Kober, Andreas Schöpfer & Gottfried Fuchs. (2022) Computed Tomography Angiography (CTA) in Selected Scenarios with Risk of Possible False-Positive or False-Negative Conclusions in Diagnosing Brain Death. Life 12:10, pages 1551.
Crossref
Bhaskar Das, Amit Kar, Rudranil Bhowmik, Sanmoy Karmakar, Satyajit Tripathy, Motlalepula G. Matsabisa & Pulok Kumar Mukherjee. (2022) Quality Related Safety Evaluation of a South African Traditional Formulation (PHELA®) as Novel Anti-Biofilm Candidate. Molecules 27:4, pages 1219.
Crossref
Zarrin Banikazemi, Seyed Mohammad Mirazimi, Fatemeh Dashti, Mohammad Reza Mazandaranian, Maryam Akbari, Korosh Morshedi, Fatemeh Aslanbeigi, Amir Rashidian, Mohsen Chamanara, Michael R. Hamblin, Mohsen Taghizadeh & Hamed Mirzaei. (2021) Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?. Frontiers in Oncology 11.
Crossref
Susanna Vichi, Franca Maria Buratti, Emma Di Consiglio, Laura Turco, Leonie S. Lautz, Keyvin Darney, Jean-Lou Christian Michel Dorne & Emanuela Testai. (2021) OpenCYP: An open source database exploring human variability in activities and frequencies of polymophisms for major cytochrome P-450 isoforms across world populations. Toxicology Letters 350, pages 267-282.
Crossref
Kavita Sharma & Neera Raghav. (2021) Curcumin analogs as anti-cathepsins agents: Designing, virtual screening, and molecular docking analysis. Computational Toxicology 19, pages 100174.
Crossref
Yang Song, Shanshan Li, Ying Shi, Lipei Zhao, Yu Cui, Lei Yao, Yu Zhen, Ruili Chen & Yan Cui. (2020) In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases. Brazilian Journal of Microbiology 52:1, pages 81-90.
Crossref
Magdalena Kowalska, Jacek Nowaczyk, Łukasz Fijałkowski & Alicja Nowaczyk. (2021) Paroxetine—Overview of the Molecular Mechanisms of Action. International Journal of Molecular Sciences 22:4, pages 1662.
Crossref
Jasleen K. Sodhi, Caroline H. Huang & Leslie Z. Benet. (2020) Volume of Distribution is Unaffected by Metabolic Drug–Drug Interactions. Clinical Pharmacokinetics 60:2, pages 205-222.
Crossref
Noha SAYED, Ikue MURATA, Osama ABDALLA, Omnia KILANY, Amina DESSOUKI & Kazuaki SASAKI. (2021) Effects of dapagliflozin in combination with insulin on cytochrome P450 activities in a diabetes type 1 rat model. Journal of Veterinary Medical Science 83:10, pages 1597-1603.
Crossref
Andrew Charrette, James Akingbasote, Najla Guthrie & Corey J. Hilmas. 2021. Nutraceuticals. Nutraceuticals 625 659 .
Yongmei Li, Michelle McCabe, Lalitha Podila, Timothy S. Tracy & Donald Tweedie. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism 665 684 .
Olavi Pelkonen, Jukka Hakkola, Janne Hukkanen & Miia Turpeinen. (2020) CYP-associated drug–drug interactions: A mission accomplished?. Archives of Toxicology 94:11, pages 3931-3934.
Crossref
G. Kaur, S. K. Gupta, P. Singh, V. Ali, V. Kumar & M. Verma. (2020) Drug-metabolizing enzymes: role in drug resistance in cancer. Clinical and Translational Oncology 22:10, pages 1667-1680.
Crossref
Helen S. Pentikis, Nikki Adetoro & Gregory Kaufman. (2020) In vitro metabolic profile and drug‐drug interaction assessment of secnidazole, a high‐dose 5‐nitroimidazole antibiotic for the treatment of bacterial vaginosis. Pharmacology Research & Perspectives 8:4.
Crossref
Esra Küpeli Akkol, Yasin Genç, Büşra Karpuz, Eduardo Sobarzo-Sánchez & Raffaele Capasso. (2020) Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer. Cancers 12:7, pages 1959.
Crossref
Harutoshi Kato. (2020) Computational prediction of cytochrome P450 inhibition and induction. Drug Metabolism and Pharmacokinetics 35:1, pages 30-44.
Crossref
Yu. I. Chernyak & A. P. Merinova. (2020) CYP3A Polymorphism and Chronic Mercury Intoxication. Bulletin of Experimental Biology and Medicine 168:4, pages 492-495.
Crossref
Angela van der Plas, Sandrine Pouly, Nicolas Blanc, Christelle Haziza, Guillaume de La Bourdonnaye, Bjorn Titz, Julia Hoeng, Nikolai V. Ivanov, Brindusa Taranu & Annie Heremans. (2020) Impact of switching to a heat-not-burn tobacco product on CYP1A2 activity. Toxicology Reports 7, pages 1480-1486.
Crossref
Katherine E. Horak, Christopher M. Campton & Steven F. Volker. (2020) Are reports of reduced field efficacy of diphacinone and chlorophacinone in California ground squirrels (Otospermophilus beecheyi) due to elevated rodenticide metabolism?. Crop Protection 127, pages 104969.
Crossref
Adrian J. Fretland, Tashinga E. Bapiro, Barry Jones, Roshini Markandu, Alexandra L. Orton & Venkatesh Pilla Reddy. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters 213 236 .
Nariman Maroufpour, Mahdieh Mousavi, Behnam Asgari Lajayer & Mansour Ghorbanpour. 2020. Biogenic Nano-Particles and their Use in Agro-ecosystems. Biogenic Nano-Particles and their Use in Agro-ecosystems 173 185 .
Kaoru Kobayashi, Jiro Kuze, Satoshi Abe, Shoko Takehara, Genki Minegishi, Katsuhide Igarashi, Satoshi Kitajima, Jun Kanno, Takushi Yamamoto, Mitsuo Oshimura & Yasuhiro Kazuki. (2019) CYP3A4 Induction in the Liver and Intestine of Pregnane X Receptor/CYP3A-Humanized Mice: Approaches by Mass Spectrometry Imaging and Portal Blood Analysis. Molecular Pharmacology 96:5, pages 600-608.
Crossref
O. S. Pshenichnikova, M. V. Goncharova, Y. S. Pustovoit, I. V. Karpova & V. L. Surin. (2019) PILOT RESEARCH OF A GENETIC PREDISPOSITION FOR CLINICAL MANIFESTATIONS OF ACUTE INTERMITTENT PORPHYRIA. Russian journal of hematology and transfusiology 64:2, pages 123-137.
Crossref
Marc Augustin, Georgios Schoretsanitis, Philippe Pfeifer, Gerhard Gründer, Claus Liebe & Michael Paulzen. (2019) Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations. Schizophrenia Research 210, pages 143-148.
Crossref
Franziska Gaunitz, Patrick Dahm, Lukas Mogler, Andreas Thomas, Mario Thevis & Katja Mercer-Chalmers-Bender. (2019) In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples. Analytical and Bioanalytical Chemistry 411:16, pages 3561-3579.
Crossref
Hansen Murcia, Andrés Cruz, Jeffrey León & Miguel Ángel González-Curbelo. (2019) Study on the inhibitory effect of furafylline and troleandomycin in the 7-methoxyresorufin-O-demethylase and nifedipine oxidase activities in hepatic microsomes from four poultry species using high-performance liquid chromatography coupled with fluorescence and ultraviolet detection. Journal of Pharmaceutical and Biomedical Analysis 164, pages 148-154.
Crossref
Li Shangguan, Yuanqing Wei, Kan Wang, Yuanjian Zhang & Songqin Liu. (2019) Highly sensitive fluorescent bioassay of 2,3,7,8-tetrachloro-dibenzo-p-dioxin based on abnormal expression of cytochrome P450 1A2 in human cells. Analytica Chimica Acta 1046, pages 179-184.
Crossref
Tania E. Perez Jimenez, Katrina L. Mealey, Darren Schnider, Tamara L. Grubb, Stephen A. Greene & Michael H. Court. (2018) Identification of canine cytochrome P‐450s ( CYP s) metabolizing the tramadol (+)‐M1 and (+)‐M2 metabolites to the tramadol (+)‐M5 metabolite in dog liver microsomes . Journal of Veterinary Pharmacology and Therapeutics 41:6, pages 815-824.
Crossref
Mohammed S. Al-Dosari & Mohammad K. Parvez. (2018) Novel plant inducers of PXR-dependent cytochrome P450 3A4 expression in HepG2 cells. Saudi Pharmaceutical Journal 26:8, pages 1069-1072.
Crossref
Jukka Hakkola, Camilla Bernasconi, Sandra Coecke, Lysiane Richert, Tommy B. Andersson & Olavi Pelkonen. (2018) Cytochrome P450 Induction and Xeno‐Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator‐Activated Receptor α at the Crossroads of Toxicokinetics and Toxicodynamics. Basic & Clinical Pharmacology & Toxicology 123:S5, pages 42-50.
Crossref
Sidika Sakalli, Pham Thai Giang, Viktoriia Burkina, Galia Zamaratskaia, Martin Krøyer Rasmussen, Tomas Bakal, Sarvenaz Khalili Tilami, Sabine Sampels, Jitka Kolarova, Roman Grabic, Jan Turek, Tomas Randak & Vladimir Zlabek. (2018) The effects of sewage treatment plant effluents on hepatic and intestinal biomarkers in common carp (Cyprinus carpio). Science of The Total Environment 635, pages 1160-1169.
Crossref
Sreelatha B.ShyamPrasad G.Koteshwar Rao V.Girisham S.. (2018) Microbial synthesis of mammalian metabolites of spironolactone by thermophilic fungus Thermomyces lanuginosus. Steroids 136, pages 1-7.
Crossref
Linlin Zhao & Hao Zhu. 2018. Computational Toxicology. Computational Toxicology 291 312 .
Russell J. Amato, Joseph Boland, Nicole Myer, Lauren Few & Daniel Dowd. (2018) Pharmacogenomics and Psychiatric Clinical Care. Journal of Psychosocial Nursing and Mental Health Services 56:1, pages 22-31.
Crossref
Ao Li, Claudia Turro & Jeremy J. Kodanko. (2018) Ru( ii ) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles . Chemical Communications 54:11, pages 1280-1290.
Crossref
Selçuk Özdemir, Serdar Altun & Harun Arslan. (2018) Imidacloprid exposure cause the histopathological changes, activation of TNF-α, iNOS, 8-OHdG biomarkers, and alteration of caspase 3, iNOS, CYP1A, MT1 gene expression levels in common carp (Cyprinus carpio L.). Toxicology Reports 5, pages 125-133.
Crossref
Aleksandra Szopa, Urszula Doboszewska, Mariola Herbet, Sylwia Wośko, Elżbieta Wyska, Katarzyna Świąder, Anna Serefko, Agnieszka Korga, Aleksandra Wlaź, Andrzej Wróbel, Marta Ostrowska, Joanna Terlecka, Adam Kanadys, Ewa Poleszak, Jarosław Dudka & Piotr Wlaź. (2017) Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt , Slc6a15 and Adora1 gene expression. Toxicology and Applied Pharmacology 337, pages 95-103.
Crossref
Elham Ahmadian, Aziz Eftekhari, Javad Khalili Fard, Hossein Babaei, Alireza Mohajjel Nayebi, Daryoush Mohammadnejad & Mohammad Ali Eghbal. (2016) In vitro and in vivo evaluation of the mechanisms of citalopram-induced hepatotoxicity. Archives of Pharmacal Research 40:11, pages 1296-1313.
Crossref
Anne E. Barden, Venus Chavez, Michael Phillips, Emilie Mas, Lawrence J. Beilin, Kevin D. Croft, Trevor A. Mori & Ian B. Puddey. (2017) A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men. Alcoholism: Clinical and Experimental Research 41:10, pages 1666-1674.
Crossref
Veronika Tomankova, Pavel Anzenbacher & Eva Anzenbacherova. (2017) Effects of obesity on liver cytochromes P450 in various animal models. Biomedical Papers 161:2, pages 144-151.
Crossref
Tsutomu Shimada. (2017) Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity. Toxicological Research 33:2, pages 79-96.
Crossref
Kerstin IfflandFranjo Grotenhermen. (2017) An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis and Cannabinoid Research 2:1, pages 139-154.
Crossref
Alphienes Stanley Xavier, Saka Vinod Kumar, Rajan Sundaram, Jose Francis & Deepak Gopal Shewade. (2016) Effect of antituberculosis treatment on CYP 2C19 enzyme activity in genetically polymorphic South Indian Tamilian population . Fundamental & Clinical Pharmacology 30:6, pages 607-615.
Crossref
Xiao-qian Xu, Ting Geng, She-bing Zhang, Dan-yu Kang, Yan-jing Li, Gang Ding, Wen-zhe Huang, Zhen-zhong Wang & Wei Xiao. (2016) Inhibition of Re Du Ning Injection on Enzyme Activities of Rat Liver Microsomes Using Cocktail Method. Chinese Herbal Medicines 8:3, pages 231-241.
Crossref
Yury I. Chernyak, Alla P. Merinova, Andrey A. Shelepchikov, Sergey I. Kolesnikov & Jean A. Grassman. (2016) Impact of dioxins on antipyrine metabolism in firefighters. Toxicology Letters 250-251, pages 35-41.
Crossref
Aleksandra Szopa, Ewa Poleszak, Elżbieta Wyska, Anna Serefko, Sylwia Wośko, Aleksandra Wlaź, Mateusz Pieróg, Andrzej Wróbel & Piotr Wlaź. (2015) Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 389:2, pages 211-221.
Crossref
Katherine E. Horak, Steven F. Volker & Christopher M. Campton. (2015) Increased diphacinone and chlorophacinone metabolism in previously exposed wild caught voles, Microtus californicus. Crop Protection 78, pages 35-39.
Crossref
Brian G. Lake & Roger J. Price. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics 309 332 .
Ewa Poleszak, Aleksandra Szopa, Elżbieta Wyska, Sylwia Wośko, Anna Serefko, Aleksandra Wlaź, Mateusz Pieróg, Andrzej Wróbel & Piotr Wlaź. (2015) The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice. Life Sciences 136, pages 13-18.
Crossref
Kuldipsinh P. Barot, Shailesh V. Jain, Laurent Kremer, Shubhra Singh & Manjunath D. Ghate. (2015) Recent advances and therapeutic journey of coumarins: current status and perspectives. Medicinal Chemistry Research 24:7, pages 2771-2798.
Crossref
Apexa Bernard, Nicole Vaccaro, Milin Acharya, James Jiao, Johan Monbaliu, Ronald De Vries, Hans Stieltjes, Margaret Yu, Namphuong Tran & Caly Chien. (2014) Impact on abiraterone pharmacokinetics and safety: Open‐label drug–drug interaction studies with ketoconazole and rifampicin. Clinical Pharmacology in Drug Development 4:1, pages 63-73.
Crossref
Julia Dinger, Markus R. Meyer & Hans H. Maurer. (2014) Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicology Letters 230:1, pages 28-35.
Crossref
Monica Mazzarino, Xavier de la Torre, Ilaria Fiacco, Amelia Palermo & Francesco Botrè. (2014) Drug‐drug interaction and doping, part 1: An in vitro study on the effect of non‐prohibited drugs on the phase I metabolic profile of toremifene . Drug Testing and Analysis 6:5, pages 482-491.
Crossref
Jan‐Peer Elshoff, Willi Cawello, Jens‐Otto Andreas & Marina Braun. (2014) No influence of the CYP2C19‐selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine. Clinical Pharmacology in Drug Development 3:3, pages 187-193.
Crossref
Khaled Abass, Petri Reponen, Sampo Mattila, Arja Rautio & Olavi Pelkonen. (2014) Human variation and CYP enzyme contribution in benfuracarb metabolism in human in vitro hepatic models. Toxicology Letters 224:2, pages 300-309.
Crossref
Yongmei Li, Michelle McCabe, Lalitha Podila, Timothy S. Tracy & Donald J. Tweedie. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism 441 460 .
Ran-Ran Zhang, Takanori Takebe, Leina Miyazaki, Maho Takayama, Hiroyuki Koike, Masaki Kimura, Masahiro Enomura, Yun-Wen Zheng, Keisuke Sekine & Hideki Taniguchi. 2014. Stem Cells and Tissue Repair. Stem Cells and Tissue Repair 131 141 .
Yu. I. Chernyak, V. B. Itskovich, O. A. D’yakovich & S. I. Kolesnikov. (2013) Role of Cytochrome P450-Dependent Monooxygenases and Polymorphic Variants of GSTT1 and GSTM1 Genes in the Formation of Brain Lesions in Individuals Chronically Exposed to Mercury. Bulletin of Experimental Biology and Medicine 156:1, pages 15-18.
Crossref
Seda Savranoglu & Tugba Boyunegmez Tumer. (2013) Inhibitory Effects of Spirulina platensis on Carcinogen-Activating Cytochrome P450 Isozymes and Potential for Drug Interactions . International Journal of Toxicology 32:5, pages 376-384.
Crossref
Teresa Cabaleiro, Rosario López‐Rodríguez, Dolores Ochoa, Manuel Román, Jesús Novalbos & Francisco Abad‐Santos. (2013) Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects. Human Psychopharmacology: Clinical and Experimental 28:3, pages 205-214.
Crossref
Gang Xie, Dingying Zhou, Ka-Wing Cheng, Chi C. Wong & Basil Rigas. (2013) Comparative in vitro metabolism of phospho-tyrosol-indomethacin by mice, rats and humans. Biochemical Pharmacology 85:8, pages 1195-1202.
Crossref
Roman Řemínek, Jochen Pauwels, Xu Wang, Jos Hoogmartens, Zdeněk Glatz & Ann Van Schepdael. 2013. Capillary Electrophoresis and Microchip Capillary Electrophoresis. Capillary Electrophoresis and Microchip Capillary Electrophoresis 309 318 .
Kristiina M. Huttunen, Niina Tani, Risto O. Juvonen, Hannu Raunio & Jarkko Rautio. (2012) Design, Synthesis, and Evaluation of Novel Cyclic Phosphates of 5-Aminosalicylic Acid as Cytochrome P450-Activated Prodrugs. Molecular Pharmaceutics 10:2, pages 532-537.
Crossref
Kristina Beijer, Kai Gao, Maria E. Jönsson, D.G. Joakim Larsson, Björn Brunström & Ingvar Brandt. (2013) Effluent from drug manufacturing affects cytochrome P450 1 regulation and function in fish. Chemosphere 90:3, pages 1149-1157.
Crossref
Gang Xie, Chi C. Wong, Ka-Wing Cheng, Liqun Huang, Panayiotis P. Constantinides & Basil Rigas. (2012) In Vitro and In Vivo Metabolic Studies of Phospho-aspirin (MDC-22). Pharmaceutical Research 29:12, pages 3292-3301.
Crossref
Verònica Ventura, Josep Solà, Concepción Peraire, Françoise Brée & Rosendo Obach. (2012) In Vitro Evaluation of the Interaction Potential of Irosustat with Drug-Metabolizing Enzymes. Drug Metabolism and Disposition 40:7, pages 1268-1278.
Crossref
Lay Kek Teh & Leif Bertilsson. (2012) Pharmacogenomics of CYP2D6: Molecular Genetics, Interethnic Differences and Clinical Importance. Drug Metabolism and Pharmacokinetics 27:1, pages 55-67.
Crossref
Daniel Knobeloch, Sabrina Ehnert, Lilianna Schyschka, Peter Büchler, Michael Schoenberg, Jörg Kleeff, Wolfgang E. Thasler, Natascha C. Nussler, Patricio Godoy, Jan Hengstler & Andreas K. Nussler. 2012. Human Cell Culture Protocols. Human Cell Culture Protocols 99 120 .
Dong Hee Na, Hye Young Ji, Eun Ji Park, Myung Sun Kim, Kwang-Hyeon Liu & Hye Suk Lee. (2011) Evaluation of metabolism-mediated herb-drug interactions. Archives of Pharmacal Research 34:11, pages 1829-1842.
Crossref
Yu. I. Chernyak, V. B. Itskovich & S. I. Kolesnikov. (2011) Effects of CYP1A2 Gene Polymorphisms on Antipyrine CYP1A2-Dependent Metabolism. Bulletin of Experimental Biology and Medicine 151:4, pages 445-448.
Crossref
Sergii Novotarskyi, Iurii Sushko, Robert Körner, Anil Kumar Pandey & Igor V. Tetko. (2011) A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition. Journal of Chemical Information and Modeling 51:6, pages 1271-1280.
Crossref
Marjo Volotinen, Jukka Hakkola, Olavi Pelkonen, Heikki Vapaatalo & Jukka Mäenpää. (2011) Metabolism of Ophthalmic Timolol: New Aspects of an Old Drug. Basic & Clinical Pharmacology & Toxicology 108:5, pages 297-303.
Crossref
Teijo I. Saari, Mikko Uusi-Oukari, Jouni Ahonen & Klaus T. Olkkola. (2011) Enhancement of GABAergic Activity: Neuropharmacological Effects of Benzodiazepines and Therapeutic Use in Anesthesiology. Pharmacological Reviews 63:1, pages 243-267.
Crossref
Kevin C. Brown & Angela D. M. Kashuba. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases 11 41 .
Kathleen Boehme, Yasmin Dietz, Philip Hewitt & Stefan O. Mueller. (2010) Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens in vitro. Toxicology Letters 198:2, pages 272-281.
Crossref
Winnie Jeng & Peter G. Wells. (2010) Reduced 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)-Initiated Oxidative DNA Damage and Neurodegeneration in Prostaglandin H Synthase-1 Knockout Mice. ACS Chemical Neuroscience 1:5, pages 366-380.
Crossref
Khaled Abass, Petri Reponen, Sampo Mattila & Olavi Pelkonen. (2010) Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chemico-Biological Interactions 185:3, pages 163-173.
Crossref
Olavi Pelkonen, Ari Tolonen, Miia Turpeinen & Jouko Uusitalo. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 32 .
V Baliharová, L Skálová, R F M Maas, G de Vrieze, S Bull & J Fink-Gremmels. (2003) The effects of mebendazole on P4501A activity in rat hepatocytes and HepG2 cells. Comparison with tiabendazole and omeprazole. Journal of Pharmacy and Pharmacology 55:6, pages 773-781.
Crossref
Chuang Lu, Suresh K. Balani, Mark G. Qian, Shimoga R. Prakash, Patricia S. Ducray & Lisa L. von Moltke. (2010) Quantitative Prediction and Clinical Observation of a CYP3A Inhibitor-Based Drug-Drug Interactions with MLN3897, a Potent C-C Chemokine Receptor-1 Antagonist. Journal of Pharmacology and Experimental Therapeutics 332:2, pages 562-568.
Crossref
Nalu Navarro-Alvarez, Alejandro Soto-Gutierrez & Naoya Kobayashi. 2010. Hepatocytes. Hepatocytes 181 236 .
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development 55 107 .
Onur Dagliyan, I. Halil Kavakli & Metin Turkay. (2009) Classification of Cytochrome P450 Inhibitors with Respect to Binding Free Energy and pIC 50 Using Common Molecular Descriptors . Journal of Chemical Information and Modeling 49:10, pages 2403-2411.
Crossref
Huw B. Jones, Terry C. Orton & Brian G. Lake. (2009) Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL/10J mouse. Food and Chemical Toxicology 47:6, pages 1333-1340.
Crossref
Yangfan YangKaili WuHongzhi YuanMinbin Yu. (2009) Cytochrome Oxidase 2D6 Gene Polymorphism in Primary Open-Angle Glaucoma With Various Effects to Ophthalmic Timolol. Journal of Ocular Pharmacology and Therapeutics 25:2, pages 163-172.
Crossref
Yukihiro Hirose, Hirohisa Nagahori, Tomoya Yamada, Yoshihito Deguchi, Yoshitaka Tomigahara, Kazuhiko Nishioka, Satoshi Uwagawa, Satoshi Kawamura, Naohiko Isobe, Brian G. Lake & Yasuyoshi Okuno. (2009) Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. Toxicology 258:1, pages 64-69.
Crossref
Nalu Navarro-Alvarez, Alejandro Soto-Gutierrez & Naoya Kobayashi. 2009. Regulatory Networks in Stem Cells. Regulatory Networks in Stem Cells 439 469 .
Brian G. Lake, Roger J. Price, Amanda M. Giddings & David G. Walters. 2009. Hepatocyte Transplantation. Hepatocyte Transplantation 47 58 .
Mark J. Graham & Brian G. Lake. (2008) Induction of drug metabolism: Species differences and toxicological relevance. Toxicology 254:3, pages 184-191.
Crossref
Lionel Perrin, Caroline Aninat, Véronique Hamon, Yoshio Hayashi, Catherine Abadie, Bruno Heyd, François André & Marcel Delaforge. (2008) Metabolism of Phenylahistin Enantiomers by Cytochromes P450: A Possible Explanation for Their Different Cytotoxicity. Drug Metabolism and Disposition 36:11, pages 2381-2392.
Crossref
A. M. Abd El-Aty, Syed Sher Shah, Bo-Mee Kim, Jeong-Heui Choi, Hee-Jung Cho, Hee-Yi, Byung-Joon Chang, Ho-Chul Shin, Kang Bong Lee, Minoru Shimoda & Jae-Han Shim. (2008) In Vitro inhibitory potential of decursin and decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic microsomes. Archives of Pharmacal Research 31:11, pages 1425-1435.
Crossref
Olavi Pelkonen, Miia Turpeinen, Jukka Hakkola, Paavo Honkakoski, Janne Hukkanen & Hannu Raunio. (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Archives of Toxicology 82:10, pages 667-715.
Crossref
S Ehnert, A. K. Nussler, A. Lehmann & S. Dooley. (2008) Blood Monocyte-Derived Neohepatocytes as in Vitro Test System for Drug Metabolism. Drug Metabolism and Disposition 36:9, pages 1922-1929.
Crossref
Ryuichi Kitamura, Hisae Asanoma, Sekio Nagayama & Masaki Otagiri. (2008) Identification of Human Liver Cytochrome P450 Isoforms Involved in Autoinduced Metabolism of the Antiangiogenic Agent ( Z )-5-[(1,2-Dihydro-2-oxo-3 H -indol-3-ylidene)methyl]-2,4-dimethyl-1 H -pyrrole-3-propanoic Acid (TSU-68) . Drug Metabolism and Disposition 36:6, pages 1003-1009.
Crossref
Tuomas Korhonen, Miia Turpeinen, Ari Tolonen, Kari Laine & Olavi Pelkonen. (2008) Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone. The Journal of Steroid Biochemistry and Molecular Biology 110:1-2, pages 56-66.
Crossref
Marjo J. Karjalainen, Pertti J. Neuvonen & Janne T. Backman. (2008) Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo. European Journal of Clinical Pharmacology 64:5, pages 511-519.
Crossref
Miki Katoh, Chise Tateno, Katsutoshi Yoshizato & Tsuyoshi Yokoi. (2008) Chimeric mice with humanized liver. Toxicology 246:1, pages 9-17.
Crossref
Gerhard Friedrich, Thorsten Rose, Alexander Wawkuschewski, Sabine Kafert-Kasting, Britta Laube, Lubomir Arseniev & Klaus Rissler. (2007) Determination of Testosterone Metabolites in Rat Hepatocytes with and without Cryopreservation by On-Line SPE Column-Switching LC and MS Detection. Chromatographia 67:1-2, pages 31-39.
Crossref
Roger J. Price, Amanda M. Giddings, Mary P. Scott, David G. Walters, Charles C. Capen, Thomas G. Osimitz & Brian G. Lake. (2008) Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. Toxicology 243:1-2, pages 84-95.
Crossref
Caroline Améen, Raimund Strehl, Petter Björquist, Anders Lindahl, Johan Hyllner & Peter Sartipy. (2008) Human embryonic stem cells: Current technologies and emerging industrial applications. Critical Reviews in Oncology/Hematology 65:1, pages 54-80.
Crossref
Christophe Arbus, Amine Benyamina, Pierre-Michel Llorca, Franck Baylé, Norbert Bromet, Frédéric Massiere, Ricardo P. Garay & Ahcène Hameg. (2007) Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine. European Journal of Pharmaceutical Sciences 32:4-5, pages 357-366.
Crossref
Daisuke Nakashima, Hirotaka Takama, Yuko Ogasawara, Tetsuyoshi Kawakami, Tsuyoshi Nishitoba, Sakuo Hoshi, Eiji Uchida & Hideji Tanaka. (2013) Effect of Cinacalcet Hydrochloride, a New Calcimimetic Agent, on the Pharmacokinetics of Dextromethorphan: In Vitro and Clinical Studies. The Journal of Clinical Pharmacology 47:10, pages 1311-1319.
Crossref
A. Lahoz, M.T. Donato, L. Picazo, M.J. Gómez-Lechón & J.V. Castell. (2007) Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry. Toxicology in Vitro 21:7, pages 1247-1252.
Crossref
Khaled Abass, Petri Reponen, Miia Turpeinen, Jorma Jalonen & Olavi Pelkonen. (2007) Characterization of Diuron N -Demethylation by Mammalian Hepatic Microsomes and cDNA-Expressed Human Cytochrome P450 Enzymes . Drug Metabolism and Disposition 35:9, pages 1634-1641.
Crossref
Ryuichi Kitamura, Yoshio Yamamoto, Sekio Nagayama & Masaki Otagiri. (2007) Decrease in Plasma Concentrations of Antiangiogenic Agent TSU-68 (( Z )-5-[(1,2-Dihydro-2-oxo-3 H -indol-3-ylidene)methyl]-2,4-dimethyl-1 H -pyrrole-3-propanoic acid) during Oral Administration Twice a Day to Rats . Drug Metabolism and Disposition 35:9, pages 1611-1616.
Crossref
T Saussele, O Burk, J K Blievernicht, K Klein, A Nussler, N Nussler, J G Hengstler, M Eichelbaum, M Schwab & U M Zanger. (2007) Selective Induction of Human Hepatic Cytochromes P450 2B6 and 3A4 by Metamizole. Clinical Pharmacology & Therapeutics 82:3, pages 265-274.
Crossref
Monica Ek, Therese Söderdahl, Barbara Küppers-Munther, Josefina Edsbagge, Tommy B. Andersson, Petter Björquist, Ian Cotgreave, Bengt Jernström, Magnus Ingelman-Sundberg & Inger Johansson. (2007) Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. Biochemical Pharmacology 74:3, pages 496-503.
Crossref
Marjo Volotinen, Miia Turpeinen, Ari Tolonen, Jouko Uusitalo, Jukka Mäenpää & Olavi Pelkonen. (2007) Timolol Metabolism in Human Liver Microsomes Is Mediated Principally by CYP2D6. Drug Metabolism and Disposition 35:7, pages 1135-1141.
Crossref
David O. Warner. (2007) Tobacco control for anesthesiologists. Journal of Anesthesia 21:2, pages 200-211.
Crossref
Fan He, Hui‐chang Bi, Zhi‐yong Xie, Zhong Zuo, Jian‐kang Li, Xin Li, Li‐zi Zhao, Xiao Chen & Min Huang. (2007) Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high‐throughput inhibition screening of terpenoids. Rapid Communications in Mass Spectrometry 21:5, pages 635-643.
Crossref
Kristiina M. Huttunen, Niina Mähönen, Jukka Leppänen, Jouko Vepsäläinen, Risto O. Juvonen, Hannu Raunio, Hanna Kumpulainen, Tomi Järvinen & Jarkko Rautio. (2007) Novel Cyclic Phosphate Prodrug Approach for Cytochrome P450-activated Drugs Containing an Alcohol Functionality. Pharmaceutical Research 24:4, pages 679-687.
Crossref
Khaled Abass, Petri Reponen, Jorma Jalonen & Olavi Pelkonen. (2007) In vitro metabolism and interaction of profenofos by human, mouse and rat liver preparations. Pesticide Biochemistry and Physiology 87:3, pages 238-247.
Crossref
Berith F. Jensen, Christian Vind, Søren B. Padkjær, Per B. Brockhoff & Hanne H. F. Refsgaard. (2007) In Silico Prediction of Cytochrome P450 2D6 and 3A4 Inhibition Using Gaussian Kernel Weighted k -Nearest Neighbor and Extended Connectivity Fingerprints, Including Structural Fragment Analysis of Inhibitors versus Noninhibitors . Journal of Medicinal Chemistry 50:3, pages 501-511.
Crossref
Neal E. Ready, Alan Lipton, Yali Zhu, Paul Statkevich, Emily Frank, Dolores Curtis & Ronald M. Bukowski. (2007) Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Weekly Paclitaxel in Patients with Solid Tumors. Clinical Cancer Research 13:2, pages 576-583.
Crossref
Tomoko Akutsu, Kaoru Kobayashi, Koichi Sakurada, Hiroshi Ikegaya, Tomomi Furihata & Kan Chiba. (2007) Identification of Human Cytochrome P450 Isozymes Involved in Diphenhydramine N -Demethylation . Drug Metabolism and Disposition 35:1, pages 72-78.
Crossref
Chuang Lu, Gerald T. Miwa, Shimoga R. Prakash, Liang-Shang Gan & Suresh K. Balani. (2007) A Novel Model for the Prediction of Drug-Drug Interactions in Humans Based on in Vitro Cytochrome P450 Phenotypic Data. Drug Metabolism and Disposition 35:1, pages 79-85.
Crossref
Roger J. Price, David G. Walters, John M. Finch, Karl L. Gabriel, Charles C. Capen, Thomas G. Osimitz & Brian G. Lake. (2007) A mode of action for induction of liver tumors by Pyrethrins in the rat. Toxicology and Applied Pharmacology 218:2, pages 186-195.
Crossref
Khaled Abass, Petri Reponen, Jorma Jalonen & Olavi Pelkonen. (2007) In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations. Environmental Toxicology and Pharmacology 23:1, pages 39-47.
Crossref
Thomas Fox & Jan M. Kriegl. 2007. 63 81 .
David G. Cornwell & Jiyan Ma. 2007. Vitamin E. Vitamin E 99 134 .
Y. Parmentier, M.-J. Bossant, M. Bertrand & B. Walther. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 231 257 .
Jie Zhang, Yijia Lou, Jos Hoogmartens & Ann Van Schepdael. (2006) Screening of drug metabolism by CE. ELECTROPHORESIS 27:23, pages 4827-4835.
Crossref
Miia Turpeinen, Laura E. Korhonen, Ari Tolonen, Jouko Uusitalo, Risto Juvonen, Hannu Raunio & Olavi Pelkonen. (2006) Cytochrome P450 (CYP) inhibition screening: Comparison of three tests. European Journal of Pharmaceutical Sciences 29:2, pages 130-138.
Crossref
Chuang Lu, Ping Li, Richard Gallegos, Vinita Uttamsingh, Cindy Q. Xia, Gerald T. Miwa, Suresh K. Balani & Liang-Shang Gan. (2006) Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes. Drug Metabolism and Disposition 34:9, pages 1600-1605.
Crossref
C Lindsay DeVane. (2006) Antidepressant–Drug Interactions are Potentially but Rarely Clinically Significant. Neuropsychopharmacology 31:8, pages 1594-1604.
Crossref
Francis Whalen, Juraj Sprung, Christopher M. Burkle, Darrell R. Schroeder & David O. Warner. (2006) Recent Smoking Behavior and Postoperative Nausea and Vomiting. Anesthesia & Analgesia 103:1, pages 70-75.
Crossref
Jiunn H. Lin. (2006) CYP Induction-Mediated Drug Interactions: in Vitro Assessment and Clinical Implications. Pharmaceutical Research 23:6, pages 1089-1116.
Crossref
Fatma Bchir, Mohamed Dogui, Radhia Ben Fradj, Maurice J. Arnaud & Sâad Saguem. (2006) Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects. Comptes Rendus. Biologies 329:7, pages 512-519.
Crossref
Daisuke Tenmizu, Kiyoshi Noguchi, Hidetaka Kamimura, Hisakazu Ohtani & Yasufumi Sawada. (2006) THE CANINE CYP1A2 DEFICIENCY POLYMORPHISM DRAMATICALLY AFFECTS THE PHARMACOKINETICS OF 4-CYCLOHEXYL-1-ETHYL-7-METHYLPYRIDO[2,3- D ]-PYRIMIDINE-2-(1 H )-ONE (YM-64227), A PHOSPHODIESTERASE TYPE 4 INHIBITOR . Drug Metabolism and Disposition 34:5, pages 800-806.
Crossref
Winnie Jeng, Annmarie Ramkissoon, Toufan Parman & Peter G. Wells. (2006) Prostaglandin H synthase‐catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration 1 . The FASEB Journal 20:6, pages 638-650.
Crossref
David J. Schaeffer, John A. Dellinger, Larry L. Needham & Larry G. Hansen. (2006) Serum PCB profiles in Native Americans from Wisconsin based on region, diet, age, and gender: Implications for epidemiology studies. Science of The Total Environment 357:1-3, pages 74-87.
Crossref
Zhi-Yi Zhang, Robert D. Pelletier, Y. Nancy Wong, Michiko Sugawara, Nanding Zhao & Bruce A. Littlefield. (2006) Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: Differential regulation in primary human hepatocytes versus transformed human cells. Biochemical and Biophysical Research Communications 341:2, pages 399-407.
Crossref
Sandra Coecke, Hans Ahr, Bas J. Blaauboer, Susanne Bremer, Silvia Casati, Josè Castell, Robert Combes, Raffaella Corvi, Charles L. Crespi, Michael L. Cunningham, Greetje Elaut, Brighitta Eletti, Andreas Freidig, Alessandra Gennari, Jean-François Ghersi-Egea, Andre Guillouzo, Thomas Hartung, Peter Hoet, Magnus Ingelman-Sundberg, Sharon Munn, Walter Janssens, Bernhard Ladstetter, David Leahy, Anthony Long, Annarita Meneguz, Mario Monshouwer, Siegfried Morath, Fred Nagelkerke, Olavi Pelkonen, Jessica Ponti, Pilar Prieto, Lysianne Richert, Enrico Sabbioni, Beatrice Schaack, Winfried Steiling, Emanuela Testai, Joan-Albert Vericat & Andrew Worth. (2019) Metabolism: A Bottleneck in In Vitro Toxicological Test Development . Alternatives to Laboratory Animals 34:1, pages 49-84.
Crossref
Hanna Kumpulainen, Niina Mähönen, Marja-Leena Laitinen, Marja Jaurakkajärvi, Hannu Raunio, Risto O. Juvonen, Jouko Vepsäläinen, Tomi Järvinen & Jarkko Rautio. (2006) Evaluation of Hydroxyimine as Cytochrome P450-Selective Prodrug Structure. Journal of Medicinal Chemistry 49:3, pages 1207-1211.
Crossref
Qingsu Xia, Ming W. Chou, John A. Edgar, Daniel R. Doerge & Peter P. Fu. (2006) Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine. Cancer Letters 231:1, pages 138-145.
Crossref
Vinita Uttamsingh, Chuang Lu, Gerald Miwa & Liang-Shang Gan. (2005) RELATIVE CONTRIBUTIONS OF THE FIVE MAJOR HUMAN CYTOCHROMES P450, 1A2, 2C9, 2C19, 2D6, AND 3A4, TO THE HEPATIC METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB. Drug Metabolism and Disposition 33:11, pages 1723-1728.
Crossref
Allan Okey. 2005. Pharmacogenomics, Second Edition. Pharmacogenomics, Second Edition 157 205 .
Mirko S. Faber, Alexander Jetter & Uwe Fuhr. (2005) Assessment of CYP1A2 Activity in Clinical Practice: Why, How, and When?. Basic & Clinical Pharmacology & Toxicology 97:3, pages 125-134.
Crossref
Svetlana Dimova, Peter H.M. Hoet, David Dinsdale & Benoit Nemery. (2005) Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. The International Journal of Biochemistry & Cell Biology 37:8, pages 1727-1737.
Crossref
Andres M. Kanner & Antoaneta J. Balabanov. (2005) The use of monotherapy in patients with epilepsy: An appraisal of the new antiepileptic drugs. Current Neurology and Neuroscience Reports 5:4, pages 322-328.
Crossref
Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato & Tsuyoshi Yokoi. (2005) IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER. Drug Metabolism and Disposition 33:6, pages 754-763.
Crossref
Laura E. Korhonen, Minna Rahnasto, Niina J. Mähönen, Carsten Wittekindt, Antti Poso, Risto O. Juvonen & Hannu Raunio. (2005) Predictive Three-Dimensional Quantitative Structure−Activity Relationship of Cytochrome P450 1A2 Inhibitors. Journal of Medicinal Chemistry 48:11, pages 3808-3815.
Crossref
Norman Calvey. (2005) Enzyme inducers and inhibitors: addition, subtraction and synergism. Anaesthesia & Intensive Care Medicine 6:4, pages 139-140.
Crossref
Olavi Pelkonen, Miia Turpeinen, Jouko Uusitalo, Arja Rautio & Hannu Raunio. (2005) Prediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations . Basic & Clinical Pharmacology & Toxicology 96:3, pages 167-175.
Crossref
Miia Turpeinen, Uusitalo Jouko, Jalonen Jorma & Pelkonen Olavi. (2005) Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay. European Journal of Pharmaceutical Sciences 24:1, pages 123-132.
Crossref
Anima Ghosal, Ragulan Ramanathan, Narendra S. Kishnani, Swapan K. Chowdhury & Kevin B. Alton. 2005. Identification and Quantification of Drugs, Metabolites and Metabolizing Enzymes by LC-MS. Identification and Quantification of Drugs, Metabolites and Metabolizing Enzymes by LC-MS 295 336 .
ROBERT S. PARKER, TIMOTHY J. SONTAG, JOY E. SWANSON & CHARLES C. McCORMICK. (2006) Discovery, Characterization, and Significance of the Cytochrome P450 ω‐Hydroxylase Pathway of Vitamin E Catabolism. Annals of the New York Academy of Sciences 1031:1, pages 13-21.
Crossref
Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato & Tsuyoshi Yokoi. (2004) EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER. Drug Metabolism and Disposition 32:12, pages 1402-1410.
Crossref
Gail D. Anderson. (2004) Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63:10_suppl_4.
Crossref
Hannu RaunioPäivi TaavitsainenPaavo HonkakoskiRisto JuvonenOlavi Pelkonen. (2019) In Vitro Methods in the Prediction of Kinetics of Drugs: Focus on Drug Metabolism . Alternatives to Laboratory Animals 32:4, pages 425-430.
Crossref
M. Molimard, B. Diquet & M. Strolin Benedetti. (2004) Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundamental & Clinical Pharmacology 18:4, pages 399-411.
Crossref
B. P. Sweeney. (2004) Microarrays: new pharmacogenomic tools for the Twenty-first Century. European Journal of Anaesthesiology 21:7, pages 505-508.
Crossref
Hong Wang, Yun Zhao, J. Alyce Bradbury, Joan P. Graves, Julie Foley, Joyce A. Blaisdell, Joyce A. Goldstein & Darryl C. Zeldin. (2004) Cloning, Expression, and Characterization of Three New Mouse Cytochrome P450 Enzymes and Partial Characterization of Their Fatty Acid Oxidation Activities. Molecular Pharmacology 65:5, pages 1148-1158.
Crossref
J Velı́k, V Baliharová, J Fink-Gremmels, S Bull, J Lamka & L Skálová. (2004) Benzimidazole drugs and modulation of biotransformation enzymes. Research in Veterinary Science 76:2, pages 95-108.
Crossref
Yong-Dae Kim, Hidekazu Todoroki, Tsunehiro Oyama, Toyohi Isse, Akiko Matsumoto, Tetsunosuke Yamaguchi, Heon Kim, Iwao Uchiyama & Toshihiro Kawamoto. (2004) Identification of cytochrome P450 isoforms involved in 1-hydroxylation of pyrene. Environmental Research 94:3, pages 262-266.
Crossref
B. P. Sweeney. (2004) Watson and Crick 50 years on. From double helix to pharmacogenomics. Anaesthesia 59:2, pages 150-165.
Crossref
Yoichi Naritomi, Yuriko Teramura, Shigeyuki Terashita & Akira Kagayama. (2004) Utility of Microtiter Plate Assays for Human Cytochrome P450 Inhibition Studies in Drug Discovery: Application of Simple Method for Detecting Quasi-irreversible and Irreversible Inhibitors. Drug Metabolism and Pharmacokinetics 19:1, pages 55-61.
Crossref
Michael W. Sinz. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development 75 132 .
Aiming Yu & Robert Haining. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes 375 419 .

Displaying 200 of 262 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.